Concepedia

Author

Özkan Yalkinoglu

Merck (Germany)ORCID

Also Known As

O Yalkinoglu, O. Yalkinoglu, Özkan Yalkinoglu, Ö Yalkinoglu, Ö. Yalkinoglu, Özkan Yalkinoglu

28

Publications

480

Citations

10

H-Index

26

Concepts

All Affiliations

Merck (Germany)Merck Serono (Switzerland)Columbia University Irving Medical CenterUniversity of Lausanne
ÖY

About

Özkan Yalkinoglu is an author at Merck (Germany) specializing in medicine, pharmacology, and cardiovascular imaging.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

88

2

Public Health

1

1

54

3

Immunology

1

1

15

4

Medical Laboratory Science

1

1

15

5

Pathology

1

1

15

Özkan Yalkinoglu

×

10

Publications

410

Citations

10

H-Index

YearCitations

Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin,

Neurology

2015

149

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study

James McCarthy, Özkan Yalkinoglu, Anand Odedra,

The Lancet Infectious Diseases

2021

75

Sensitivity of cross-sectional echocardiography in detection of impaired global and regional left ventricular function: prospective study

Raimund Erbel, P. Schweizer, Jürgen Meyer,

International Journal of Cardiology

1985

54

Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury

Christoph Gerdes, Verona Faber-Steinfeld, Özkan Yalkinoglu,

Arteriosclerosis Thrombosis and Vascular Biology

1996

38

Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues

Mahya Eslami, Sonia Schuepbach‐Mallepell, Daniela Diana,

Proceedings of the National Academy of Sciences

2024

24

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

Johan L. van der Plas, Vincent P. Kuiper, Wilhelmina Bagchus,

The Lancet Infectious Diseases

2023

19

Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial

Lena Klopp‐Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu,

Clinical Pharmacology & Therapeutics

2024

16

BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid

Mahya Eslami, Edgar Meinl, Hermann Eibel,

Frontiers in Cell and Developmental Biology

2020

15

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

Daniela Willen, Wolfgang Uhl, Peter Wolna,

European Journal of Drug Metabolism and Pharmacokinetics

2019

10

Comparison of POC-CCA with Kato-Katz in Diagnosing Schistosoma mansoni Infection in a Pediatric L-Praziquantel Clinical Trial

Xiaoyan Yin, Eliézer K. N’Goran, Mamadou Ouattara,

Frontiers in Tropical Diseases

2021

10

Page 1